A Clinical Study in Patients With High-risk Recurrent Primary

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03253250` - The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection	Phase 4
Terminated	`NCT01760616` - Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy	Phase 4
Active, not recruiting	`NCT04682847` - Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Not yet recruiting	`NCT03149523` - Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors	N/A
Recruiting	`NCT05009550` - ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation	N/A
Recruiting	`NCT06342414` - An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Recruiting	`NCT03132740` - Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma
Completed	`NCT03164382` - Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma	Phase 3
Completed	`NCT03572582` - Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma	Phase 2
Completed	`NCT04266548` - Arterial Base Fluorescence Segmental Positive Staining	N/A
Recruiting	`NCT03013712` - A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer	Phase 1/Phase 2
Recruiting	`NCT01350726` - Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan	N/A
Completed	`NCT06245798` - Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
Recruiting	`NCT06311396` - Development of a Neuronal Microscope	N/A
Recruiting	`NCT04220944` - Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.	Phase 1
Completed	`NCT02352935` - Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function	N/A
Completed	`NCT02332551` - Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder	N/A
Completed	`NCT02834780` - Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma	Phase 1
Not yet recruiting	`NCT06182865` - A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy	N/A
Completed	`NCT05007548` - to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve	Phase 2

NCT number	NCT04538313
Study type	Interventional
Source	CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 1/Phase 2
Start date	August 26, 2020
Completion date	October 31, 2022

A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms